HLA Typing for Transplant Market Size, Share Global Analysis Report, 2020–2026

Industry Insights

This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the HLA Typing for Transplant industry. The report analyzes and declares the historical and current trends analysis of the HLA Typing for Transplant industry and subsequently recommends the projected trends anticipated to be observed in the global HLA Typing for Transplant market during the upcoming years.

The global HLA Typing for Transplant market report analyzes and notifies the industry statistics at the global as well as regional and country levels in order to acquire a thorough perspective of the entire HLA Typing for Transplant market. The historical and past insights are provided for FY 2016 to FY 2019 whereas projected trends are delivered for FY 2020 to FY 2026. The quantitative and numerical data is represented in terms of value (USD Million) from FY 2016 – 2026.

The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the HLA Typing for Transplant industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.

Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the HLA Typing for Transplant industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the global HLA Typing for Transplant market.

The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders involved in the entire value chain of the HLA Typing for Transplant industry. The global HLA Typing for Transplant Market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.

The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the HLA Typing for Transplant sector. Key strategic developments in the global HLA Typing for Transplant market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the global HLA Typing for Transplant market are appropriately highlighted in the report.

HLA typing is used to recognize the HLA antigens group present in an individual. The identification of HLA-class I and class II antigens helps provide accurate testing results for further compatibility purposes in case of organ transplantation. The HLA typing tests are carried out using advanced DNA innovations.

The increasing requirement for organ donors coupled with the increasing number of transplants across the globe is projected to surge the global HLA Typing for Transplant market growth. Furthermore, the increasing number of heart, kidney, liver, lung, cancer, etc. disorders across the world is fueling market expansion. The growing geriatric population increases the instances of organ transplantation. This factor is majorly estimated to drive the market during the forecast period. Moreover, the technological advancements and the huge gap between the organ donation supply and demand chain are impeding the market expansion. The growing awareness about organ donation owing to the government and private organizations’ efforts will boost sales during the forecast timeframe. The growing healthcare infrastructure, high funding, and research grants also augment market demand. However, the expensive molecular HLA typing techniques is estimated to restrain market growth.

The global HLA Typing for Transplant market research report delivers an acute valuation and taxonomy of the HLA Typing for Transplant industry by practically splitting the market on the basis of different technology, product and services, application, end-use, and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026. The regional segmentation of the HLA Typing for Transplant industry includes the complete classification of all the major continents including North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Further, country-wise data for the HLA Typing for Transplant industry is provided for the leading economies of the world.

The global HLA Typing for Transplant market is segmented based on Technology, Product and Services, Application, and End-Use. On the basis of technology segmentation, the market is classified into Non-Molecular Assays and Molecular Assays. By product and services, the market for HLA typing for transplant is divided into Instruments, Reagents and Consumables, Software, and Services. In terms of application, the HLA Typing for Transplant market is segregated into Diagnostics and Research. Based on end-use, the market is sectored into Hospitals and Transplant Centers, Commercial Service Providers Academic Institutes and Research Laboratories.

Report Scope

Some of the essential players operating in the global HLA Typing for Transplant market, but not restricted to include

•  Pacific Biosciences of California Incorporation
•  GenDx
•  Bio-Rad Laboratories
•  Abbott Laboratories
•  CareDx Inc.
•  Omixon Inc.
•  Bio-Reference Laboratories
•  Linkage Biosciences (Thermo Fischer Scientific)
•  F. Hoffmann-La Roche Ltd.
•  Immucor Inc.
•  Luminex Corporation
•  Illumina Inc.
•  Inno-train Diagnostik GmbH
•  Qiagen.

The taxonomy of the HLA Typing for Transplant industry by its scope and segmentation is as follows:

Technology Segmentation Analysis

• Non-Molecular Assay

• Serological Assay
• Mixed Lymphocyte Culture Assay

• Molecular Assay

• PCR-based

• Sequence specific primer-PCR
• Sequence specific oligonucleotide-PCR
  • Sequencing-based

• Next Generation Sequencing
• Sanger’s Sequencing

Products and Services Segmentation Analysis

• Instruments
• Reagents and Consumables
• Software and Services

Application Segmentation Analysis

• Diagnostic
• Research

End-User Segmentation Analysis

• Hospitals and Transplant Centers
• Research Laboratories and Academic Institutions
• Commercial Service Providers

Technology Segmentation Analysis

• Non-Molecular Assay

• Serological Assay
• Mixed Lymphocyte Culture Assay

• Molecular Assay

• PCR-based

• Sequence specific primer-PCR
• Sequence specific oligonucleotide-PCR
  • Sequencing-based

• Next Generation Sequencing
• Sanger’s Sequencing

Products and Services Segmentation Analysis

• Instruments
• Reagents and Consumables
• Software and Services

Application Segmentation Analysis

• Diagnostic
• Research

End-User Segmentation Analysis

• Hospitals and Transplant Centers
• Research Laboratories and Academic Institutions
• Commercial Service Providers

Regional Segmentation Analysis

• North America
  • The U.S.
  • Canada
• Europe
  • Germany
  • The UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa